These data suggest that high KRAS expression levels had effects at severe stages; correlation analysis showed in ACC, COAD, ESCA, KIRC, KIRP, LIHC, MESO, SKCM and STAD (Figures 3A–I). This evidence concerns the gene KRAS and adrenal cortex carcinoma.